Otsuka_Patient_Assistance_Foundation_KO_Logo Otsuka_Patient_Assistance_Foundation_KO_Logo ABILIFY MAINTENA® (aripiprazole) JYNARQUE® (tolvaptan) REXULTI® (brexpiprazole) SAMSCA® (tolvaptan) $ R x

THIS SECTION IS FOR PATIENTS ONLY

You can begin the application process by applying via the OPAF Care Connect Patient Portal. The OPAF team will work with your healthcare professional [HCP] to finish the application process. Please follow the instructions below to begin this process.

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA®(tolvaptan) tablets.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

OPAF Care Connect Benefits

Patients Can Apply Online

Submit and manage your OPAF application from start to finish:

Time Icon

Receive eligibility determination within 2 business days

Briefcase Icon

Use your work space to find your application and more

Email Icon

Email patient eConsent and HCP eSignatures for a seamless application process

Patients Icon

View your application online

Find Documents Quickly and Easily

Access relevant your documentation and treatment information in a secure, online location:

Search Icon

Search for patient information quickly with My Case Search

Application Icon

Initiate annual applications from existing patient case information

eConsent Form Icon

Access eConsent forms for future assistance applications

Get Up-to-Date and Timely Notifications

Stay informed with email notifications for your applications and product requests:

Cloud Icon

Get updates regarding your application status and determination results

Alert Icon

Receive notifications when it’s time for annual re-enrollment

Shipment Icon

Track the status of product shipments

Prefer to fax in your application? Just follow these 3 simple steps:

  1. Download and print the application
  2. Collect all required documentation from your patient
  3. Fax the application and the documentation to OPAF at 1-844-727-6274

Please note: Faxed applications are processed within 5 business days. If this is a time-sensitive request, please submit an application online

If you are applying for assistance for ABILIFY MAINTENA®(aripiprazole) extended release injectable suspension:

Download application for assistance for ABILIFY MAINTENA®(aripiprazole) extended release Injectable suspension

If you are applying for assistance for REXULTI®(brexpiprazole) tablets:

Download application for assistance for REXULTI®(brexpiprazole) tablets

If you are applying for assistance for SAMSCA®(tolvaptan) tablets:

Download application for assistance for SAMSCA®(tolvaptan) tablets

If you are applying for assistance for JYNARQUE®(tolvaptan) tablets:

Download application for assistance for JYNARQUE®(tolvaptan) tablets

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA®(tolvaptan) tablets.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

 

To help expedite the patient’s application, be sure to include the proper documentation with your fax, including:

 

  • Proof of income
  • Proof of US Address 

Have Any Questions?

See OPAF FAQs

The Otsuka Patient Assistance Foundation, Inc. (OPAF) recognizes that patients face unique challenges that negatively impact their health journey. OPAF is dedicated to being a foundation of excellence that focuses on providing free health & wellness solutions. Hence, OPAF is excited to announce the national launch of the OPAF Resource and Solutions Center.

Patients that have been approved for assistance for their eligible Otsuka medication, may also opt-in for additional offerings via the OPAF Resource and Solutions Center, which includes:

  • Access to a variety of Nature Made® vitamins for free.
  • Connectivity to external health, wellness, and alternative financial resources.
  • Eligible patients may have access to select generic antidepressants, free of cost.
  • Text messaging and/or secure messaging options for easier access to OPAF Patient Access Advocates.
  • COVID-19/Natural Disaster Crisis Assistance.

If you are interested in learning more about OPAF's offerings and would like to speak with a Patient Access Advocate, please call OPAF at 1-855-727-6274 Monday-Friday 8AM-8PM EST.

April 2022PAUS22EUC0013

The Otsuka Patient Assistance Foundation, Inc. (OPAF) recognizes that patients face unique challenges that negatively impact their health journey. OPAF is dedicated to being a foundation of excellence that focuses on providing free health & wellness solutions. Hence, OPAF is excited to announce the national launch of the OPAF Resource and Solutions Center.

Patients that have been approved for assistance for their eligible Otsuka medication, may also opt-in for additional offerings via the OPAF Resource and Solutions Center, which includes:

  • Access to a variety of Nature Made® vitamins for free.
  • Connectivity to external health, wellness, and alternative financial resources.
  • Eligible patients may have access to select generic antidepressants, free of cost.
  • Text messaging and/or secure messaging options for easier access to OPAF Patient Access Advocates.
  • COVID-19/Natural Disaster Crisis Assistance.

If you are interested in learning more about OPAF's offerings and would like to speak with a Patient Access Advocate, please call OPAF at 1-855-727-6274 Monday-Friday 8AM-8PM EST.

April 2022PAUS22EUC0013

When you submit an application on behalf of a patient, please include proof of income for all members of the household who file a tax return. Acceptable documentation includes one of the following:

  • Federal Income Tax Return (1040, etc.)
  • W-2 from previous tax year
  • 1099-MISC form
  • Two most recent paystubs
  • Social Security award letter
  • Disability income information
  • Unemployment benefits letter
  • Letter from employer on company letterhead

The application must also include an acceptable proof of a US address. Acceptable documentation includes one of the following:

  • Social Security number
  • State driver’s license or State ID
  • US birth certificate
  • US passport
  • Mortgage statement or rental agreement
  • Two (2) utility bills
  • Foreign passport with US visa
  • I-94 form with photograph
  • US military ID
  • US certificate of naturalization or citizenship
  • Green card
  • Alien registration card

The application must also include insurance denial documentation. Acceptable documentation includes one of the following:

  • Explanation of benefits
  • Insurance statement
  • Prior authorization denial letter

Secure messaging ensures patient privacy because it is a HIPAA-compliant, password-protected electronic messaging platform. You can communicate directly with an OPAF Patient Case Coordinator without having to pick up the phone. Through the platform you can securely send electronic messages with any questions, communications, and documents at your convenience.

Because it is HIPAA-compliant, there is a one-time account activation process. The activation process takes less than 3 minutes. Once your account is active, you can send messages to OPAF immediately.

To setup your OPAF secure message account follow the steps below:

  • Click on the (button or envelope) below to start the process
  • The system will prompt you to enter your email address as a "New to SecureContact"
  • A verification email will be sent to the email address that you entered
  • In your email inbox, you will find a message from "[email protected]"
  • Open this message and click on the link to activate your account
  • Complete the account activation by creating a password
  • Your account is active, and you can securely send a message to OPAF

If you have any questions, please contact OPAF at 1-855-727-6274 8:00 AM - 8:00 PM EST.

Supported Medications

OPAF provides eligible patients no-cost support for the following prescribed medications:

See U.S. FULL PRESCRIBING INFORMATION, including BOXED WARNING for
ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA®(tolvaptan) tablets.

See MEDICATION GUIDES for ABILIFY MAINTENA, JYNARQUE, REXULTI, and SAMSCA.

To report SUSPECTED ADVERSE REACTIONS, contact Otsuka America Pharmaceutical, Inc. at
1-800-438-9927 or FDA at 1-800-FDA-1088 (www.fda.gov/medwatch).

Otsuka America Pharmaceutical, Inc. does not control or influence how Otsuka Patient Assistance Foundation, Inc. distributes funds.